About Geneva
Advancing Military Medicine, Ensuring Mission Success
Geneva accelerates operationally relevant, military-unique research that aligns with Department of Defense (DoD) requirements to ensure mission success. We turn innovation into action, delivering deployable medical solutions that protect the health, readiness, and capabilities of service members and the communities they serve.
Geneva operates where the mission happens—embedded at military research sites, test ranges, and laboratories worldwide. Our agile infrastructure, deep operational expertise, and commitment to collaboration enable fast, compliant, and effective R&D in complex environments.
With deep expertise in research operations, government contracting, strategic collaborations, and commercialization, Geneva is a trusted partner, helping the DoD innovate at speed and scale.
Our Mission
To advance military medicine through research, development, and education.
Our Core Values
Integrity | Superior Customer Service | Quality | Innovation | Teamwork | Respect for All
Why Military Medical Research Matters
Military medical research is essential to national defense. It safeguards the lives, performance, and survivability of service members while delivering dual-use breakthroughs that transform civilian healthcare.
Yet this vital research faces persistent barriers: budget constraints, fragmented partnerships, regulatory complexity, and stalled innovation pipelines. Geneva exists to break through those barriers, accelerating research and ensuring sustained momentum in this critical ecosystem.
Mission-Driven. Strategically Positioned. Impact-Focused.
Geneva drives medical research that strengthens national defense, enhances force readiness, and saves lives. We accelerate innovation across the full continuum of care—from discovery to deployment—by bringing together government, academia, industry, and research teams to deliver real-world, mission-ready solutions.
As a strategic convener and trusted executor within the military medical enterprise, Geneva helps collaborators navigate regulatory complexity, streamline acquisition, and bring critical solutions to the field faster.
Proven Impact. Global Reach.
With more than 30 years of experience, Geneva is a trusted engine for military medical innovation. We partner with investigators to secure and execute awards from top federal agencies, advance strategic collaborations, convene multidisciplinary teams, and translate research into real-world results.
Our model scales efficiently: managing complex programs, recruiting and deploying high-performing teams, disseminating critical research findings, and delivering value at every phase—from concept to commercialization.
Watch Our 30-Year Impact Video
Our Value Across Sectors
Geneva’s collaborative infrastructure enables partners to do more with less—navigating complexity without compromising quality. We don’t just support research; we enable it to thrive, scale, and deliver results where they matter most.
For Investigators and Research Teams
We accelerate research impact by securing competitive funding, streamlining operations, and driving results aligned with DoD priorities.
$387M in grant funding awarded annually to Geneva-supported PIs*
For Academic Institutions
We advance translational research and foster partnerships that amplify discovery and scale innovation.
Active partnerships with 49 universities and academic medical centers*
For Industry Collaborators
Geneva provides an agile, cost-efficient, compliant entry point into the defense medical ecosystem—simplifying contracting, reducing friction, and enabling co-development of deployable solutions.
Active partnerships with 95 industry partners*
For Government Stakeholders
We deliver requirements-driven solutions that modernize care, reduce costs, and enhance medical readiness while preserving the highest ethical and scientific standards.
Support to 39 DoD installations and six federal sponsors*
* Data time period Sept 1, 2024 – Sept 1, 2025
Why Geneva
Agile & Accountable: Flexible infrastructure built for compliance, scale, and speed
Mission-Aligned: Deep roots in military medicine, with a clear focus on national defense
Outcome-Oriented: A proven track record of translating research into real-world impact
Our History
Founded to address an unmet need in military medical research, Geneva has grown into a national leader in defense health R&D. Over the years, we have strengthened our role as a strategic convener, trusted executor, and partner of choice for mission-driven research.
Throughout our evolution, Geneva has remained steadfast in its mission: accelerating solutions that protect service members and enhance the nation’s medical readiness, while advancing innovation at the intersection of science, service, and strategy.
2023-Present
2023
Geneva celebrates its 30th anniversary, marking three decades of dedicated service in advancing military medicine, driving research innovation, delivering impactful solutions, and creating meaningful collaborations.
2023
Geneva opens its Frederick, MD-based research management office at the Frederick Innovative Technology Center, marking a significant growth milestone that enhances the organization’s ability to better serve its customers and engage key stakeholders.
2013-2022
2022
The Fort Bragg Research Institute (now the Fort Liberty Research Institute) opens its first physical location at the Fayetteville Cumberland Economic Development Corporation’s CORE Innovation Center, marking a significant growth milestone that enhances the Institute’s capacity to drive innovation and support research.
2022
Geneva is awarded its first subaward from the U.S. Army Combat Capabilities Development Command, Chemical Biological Center (DEVCOM CBC), and prime ERP International to deliver cutting-edge Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) research and development solutions, enhancing the warfighter’s capabilities and advancing national defense efforts.
2021
Geneva is awarded a GSA Schedule under the Multiple Award Schedule (MAS), streamlining the process for serving federal customers and expanding its ability to deliver high-impact solutions to serve its federal customers.
2021
The Biotechnology, Biomanufacturing, and Bioprinting Program (4D Bio3) is elevated by the Uniformed Services University to the USU-4D Bio3 Center for Biotechnology.
2020
Geneva is awarded a subcontract under CRO Pharm-Olam for Operation Warp Speed to support two lead COVID-19 vaccine candidates at six military treatment facilities, playing a critical role in the global pandemic response by accelerating the development of deployable vaccines.
2019
Geneva assumes management of the TriService Nursing Research Program at USU, marking a significant growth milestone that expands its capacity to drive nursing research and innovation.
2019
The Uniformed Services University issues a cooperative agreement to Geneva to facilitate the execution of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program, advancing critical research to improve recovery and readiness for service members.
2018
Geneva opens its National Capital Region Office in Bethesda, MD, expanding its presence and strengthening its ability to engage with key federal agencies, partners, and stakeholders to advance military medical research and innovation.
2017
The Uniformed Services University issues a cooperative agreement to Geneva to facilitate the execution of the 4D Biofabrication, Bioprinting, and Biomanufacturing (4DBio3) Program, advancing innovative research in biofabrication technologies with significant potential to enhance military healthcare and shape the future of medical treatments.
2016
Geneva enters into an MOU with the Uniformed Services University to collaborate on multiple initiatives aimed at advancing medical research and education within the DoD, strengthening the organization’s role in enhancing military healthcare and supporting broader medical innovation.
2015
Geneva begins supporting pharmacy resident rotations at Naval Medical Center San Diego in collaboration with the University of California San Diego, and orthopaedic resident rotations at Madigan Army Medical Center and the VA Medical Center in San Francisco in partnership with Samuel Merritt University, enhancing the development of future medical professionals and advancing military and veteran healthcare.
2015
Geneva and the Jonas Center for Nursing and Veterans Healthcare establish a partnership aimed at supporting a doctoral nursing scholar to participate in military medical research with a focus on veteran needs.
2015
Geneva is awarded its first Joint Warfighter Medical Research Program contract to support LTC Luis Alvarez at the National Cancer Institute – Frederick, marking a significant milestone in the organization’s growth and expanding its capacity to support high-impact cancer research.
2014
Geneva is awarded a contract from Naval Medical Logistics Command to support research at Naval Medical Research Center – Frederick, advancing groundbreaking joint research projects in biodefense and infectious diseases with global partners to strengthen military medical preparedness.
2014
Geneva establishes its Researcher of the Year award, recognizing Lt. Col. Vikhyat Bebarta for his pioneering contributions to advancing innovative medical research within the U.S. military, and setting a standard for excellence in military-relevant research.
2013
The signing of the 2014 National Defense Authorization Act marks a critical milestone for Geneva, officially granting privileges to collaborate directly with the Uniformed Services University, expanding its presence within the military medical research community.
2000-2012
2012
Geneva’s continued growth leads to the establishment of its Scientific Advisory Board, providing expert research guidance, ethical oversight, and advocacy to enhance the organization’s impact and uphold the highest standards in research excellence.
2010
Geneva begins collaboration with the DoD Hearing Center of Excellence, fostering critical alliances to provide research, professional, and administrative support services, and advancing efforts to improve auditory health and readiness.
2008
Geneva receives a Congressional Special Interest award to establish Centers for Targeted Radiation Therapy at Madigan Army Medical Center and the VA Puget Sound Health Care System, expanding its presence and advancing innovative cancer research.
2007
Geneva supports its first international study on the development of a malaria vaccine at the Armed Forces Research Institute of Medical Sciences in Thailand, establishing the organization’s presence on a global stage and advancing efforts to combat infectious diseases worldwide.
2006
Geneva secures its first Congressionally Directed Medical Research Program funding to study new treatments for bone infections in critically wounded soldiers, marking the beginning of a long-standing success in advancing innovative medical solutions through CDMRP.
2006
Geneva secures its first National Institutes of Health awards at Walter Reed Army Institute of Research, solidifying its presence in the broader research community and advancing studies in respiratory toxicity and lung injury.
2005
Geneva secures its first federal contract award to establish a Sponsored Research Office at Walter Reed Army Institute of Research, representing a pivotal milestone in the organization’s growth.
2003
Geneva introduces robust proposal development services, establishing a unique capability among non-profit organizations and enhancing its impact by securing funding for critical military-relevant research.
1993-2002
2002
Geneva negotiates a master agreement for research and development with the U.S. Army, expanding its reach and ability to support military-relevant research.
1997
Geneva launches its first multi-center consortium of research under the direction of the Urology Service at Madigan Army Medical Center, fostering collaborative innovation and advancing groundbreaking research to improve medical outcomes.
1996
Geneva’s current President and CEO, Elise Huszar, joins as its first Executive Director, embarking on a distinguished tenure defined by visionary leadership that laid the foundation for the organization’s transformative growth.
1996
Geneva commences management of first federal grant award from the TriService Nursing Research Program, supporting nurse researchers to drive impactful advancements in military nursing practices and improve healthcare outcomes for service members and their families.
1993: Founded
Geneva is founded by Jane Taylor, a critical care nurse, to advance military medicine and provide comprehensive research services to support the needs of Madigan Army Medical Center.
Philanthropy At Geneva
Geneva donors make an impact in advancing critical research and the opportunity for revolutionary change on a global scale. By contributing to Geneva, donors directly support researchers in their pursuit of discovery and innovation in military medicine beyond the reaches of federal research dollars.
Explore Giving Opportunities